To catch up on all of the news from this past week, listen to our weekly news brief for the week of March 2–6, 2026.
This week’s brief covers the FDA’s premarket approval of Claire, an AI-enabled imaging system designed to assess surgical margins during breast-conserving surgery; new research examining how AI pathology models may rely on correlational “shortcuts” when predicting molecular biomarkers from histology images; and the development of a deep neural network classifier that uses cerebrospinal fluid DNA methylation patterns to identify pediatric brain tumors through liquid biopsy.
To learn more about the FDA premarket approval of a new AI-enabled imaging device, read "First AI-Enabled Imaging Device for Breast Cancer Surgery Granted FDA Premarket Approval."
For more information on what's happening under the hood of AI pathology models, read "Are AI Tools in Pathology Learning True Biomarker Signals or Statistical Shortcuts?" or see the source report in Nature Biomedical Engineering.
To learn more about M-PACT for pediatric brain tumors, read "Deep Neural Network Classifier Identifies Pediatric Brain Tumors From Liquid Biopsies," or see the source report in Nature Cancer.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.